Skip to main content
Erschienen in: Virology Journal 1/2009

Open Access 01.12.2009 | Short report

Genetic predisposition to chikungunya – a blood group study in chikungunya affected families

verfasst von: Sudarsanareddy Lokireddy, Vemula Sarojamma, Vadde Ramakrishna

Erschienen in: Virology Journal | Ausgabe 1/2009

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Chikungunya fever is a viral disease transmitted to humans by the bite of CHIKV virus infected Aedes mosquitoes. During monsoon outbreak of chikungunya fever, we carried out the genetic predisposition to chikungunya in disease affected 100 families by doing blood group (ABO) tests by focusing on individuals who were likely to have a risk of chikungunya and identified the blood group involved in susceptibility/resistance to chikungunya. In the present study, based on blood group antigens, the individuals were kept in four groups – A (108), B (98), AB (20) and O (243). The result obtained was showed all Rh positive blood group individuals are susceptible to chikungunya fever. Among ABO group, the blood group O +ve individuals are more susceptible to chikungunya than other blood groups. No blood group with Rh negative was affected with chikungunya, it indicates Rh -ve more resistance to chikungunya.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1743-422X-6-77) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

LS conducted the experiments with the patients' blood. LS also performed the final statistical analysis of the data and contributed to writing the paper. VS (she is a specialist in infectious diseases) gave us guidance in selecting the chikungunya patients for research during time of blood collection. VR supervised the overall project, designed experiments, analyzed the data and wrote the paper. All authors read and approved the final manuscript.
Chikungunya, an arboviral disease transmitted by Aedes mosquitoes, has recently increased dramatically in incidence and geographic extent. Large outbreaks have affected islands of the Indian Ocean, India and other parts of South and Southeast Asia, Africa and most recently Italy [13]. Chikungunya virus is an important human pathogen, a member of the Alphavirus genus in the family Togaviridae that causes a syndrome characterized by fever, chills, headache and severe joint pain with or without swelling (usually the smaller joints). The name is derived from the Makonde word meaning 'that which bends up' in reference to the stooped posture developed as a result of the arthritic symptoms of the disease [4, 5]. The outbreak was first investigated in February 2006 in Andhra Pradesh and then in March 2006 in Karnataka by health officials of the country who confirmed the occurrence of chikungunya virus in the region [6, 7]. The outbreak in India started in the end of 2005 and has an attack rate of 4–45% [8]. No treatment or vaccine is available, and relatively little research has been conducted into pathogenesis of chikungunya, compared with that of other arboviruses, such as dengue.
Genetic factors are important in the predisposition to various diseases. Complex diseases are generally influenced by more than one gene or environmental factor, and as a consequence, do not exhibit a simple mode of inheritance. In community, although only a small percentage of exposed individuals will develop the disease. Some individuals often show variation in susceptibility/resistance to certain diseases. Therefore, host susceptibility, genetic factors and, possibly environmental factors may be important for the development of diseases. During July – October 2006 year monsoon outbreak of chikungunya fever in Southern parts of India particularly in Anantapur District of Andhra Pradesh, has led us to carryout the genetic predisposition of chikungunya in affected families to identify susceptible or resistant blood group by analyzing the blood group in the chikungunya affected people. This type of work has not been carried out by any scientific group. In the present study, we designed to focus on individuals who were likely to have a risk of chikungunya and identified the blood group involved in susceptibility/resistance to chikungunya in the chikungunya affected families.
During outbreak of chikungunya in Andhra Pradesh, India, a total of 100 chikungunya affected families from nearby villages of Sri Krishnadevaraya University, with on and average of 5 members (age of 10 – 70 years) in each family were selected based on disease symptoms for this study. Blood samples were collected from each subject with their prior written consent and identified Blood groups by using commercial blood group kit containing Anti -A, Anti-B and Anti-D monoclonal antibody reagents. Statistical analysis was performed by using GraphPad InStat software.
Among 468 individuals of 100 families surveyed, 95 subjects (20%) reported no chikungunya fever and remaining 80% suffering with all chikungunya symptoms with fever, headache, and severe joint pains. Based on blood group Antigens, the individuals were kept in four groups – A (108), B (98), AB (20) and O (243) (figure 1). Among A blood group, 98% people (106) are Rh positive and 80% (85) are suffering with chikungunya. However in the blood group B, 60% are suffering from total of 94 Rh positive. In the case of AB group, all 20 individuals are Rh positive but only 5 subjects shown chikungunya. Nearly 52% of total study group was shown O blood group. Among 243 subjects, 235 were Rh positive and 96% (227) of Rh +ve cases were shown chikungunya symptoms. No Rh negative individual of any blood group showing any type of chikungunya fever symptoms (figure 2). In the individual familial studies, we also observed that the family who is having O positive blood group is completely affected with chikungunya fever. However, within the same family the person having O negative is not showing any symptoms of chikungunya.
In conclusion, the present results state that all Rh positive blood group individuals are susceptible. Among them, the blood group O +ve individuals are more susceptible to chikungunya than other blood groups. No blood group with Rh negative was affected with chikungunya; it indicates Rh -ve more resistance to chikungunya.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

LS conducted the experiments with the patients' blood. LS also performed the final statistical analysis of the data and contributed to writing the paper. VS (she is a specialist in infectious diseases) gave us guidance in selecting the chikungunya patients for research during time of blood collection. VR supervised the overall project, designed experiments, analyzed the data and wrote the paper. All authors read and approved the final manuscript.
download
DOWNLOAD
print
DRUCKEN
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
2.
Zurück zum Zitat Chhabra M, Mittal V, Bhattacharya D, Rana UVS, Lal S: Chikungunya fever: a reemerging viral infection. Indian J Med Microbiol 2008, 26: 5-12. 10.4103/0255-0857.38850CrossRefPubMed Chhabra M, Mittal V, Bhattacharya D, Rana UVS, Lal S: Chikungunya fever: a reemerging viral infection. Indian J Med Microbiol 2008, 26: 5-12. 10.4103/0255-0857.38850CrossRefPubMed
3.
Zurück zum Zitat Townson H, Nathan MB: Resurgence of chikungunya. Transactions of the Royal Society of Tropical Medicine and Hygiene 2008, 102: 308-309.CrossRefPubMed Townson H, Nathan MB: Resurgence of chikungunya. Transactions of the Royal Society of Tropical Medicine and Hygiene 2008, 102: 308-309.CrossRefPubMed
4.
Zurück zum Zitat Pialoux G, Bernard-Alex Gaüzère, Stéphane Jauréguiberry, Michel Strobel: Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007, 7: 319-27. 10.1016/S1473-3099(07)70107-XCrossRefPubMed Pialoux G, Bernard-Alex Gaüzère, Stéphane Jauréguiberry, Michel Strobel: Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007, 7: 319-27. 10.1016/S1473-3099(07)70107-XCrossRefPubMed
5.
Zurück zum Zitat Martin E: Chikungunya: No Longer a Third World Disease. Science 2007, 318: 1860-61. 10.1126/science.318.5858.1860CrossRef Martin E: Chikungunya: No Longer a Third World Disease. Science 2007, 318: 1860-61. 10.1126/science.318.5858.1860CrossRef
6.
Zurück zum Zitat World Health Organization: Disease outbreak news. Chikungunya and dengue in the southwest Indian Ocean, 17 March 2006. Geneva World Health Organization: Disease outbreak news. Chikungunya and dengue in the southwest Indian Ocean, 17 March 2006. Geneva
7.
Zurück zum Zitat NCID: Chikungunya Fever: India and Indian Ocean Islands. 2006. NCID: Chikungunya Fever: India and Indian Ocean Islands. 2006.
Metadaten
Titel
Genetic predisposition to chikungunya – a blood group study in chikungunya affected families
verfasst von
Sudarsanareddy Lokireddy
Vemula Sarojamma
Vadde Ramakrishna
Publikationsdatum
01.12.2009
Verlag
BioMed Central
Erschienen in
Virology Journal / Ausgabe 1/2009
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-77

Weitere Artikel der Ausgabe 1/2009

Virology Journal 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.